-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Seclidemstat Mesylate in Solid Tumor
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Seclidemstat Mesylate in Solid TumorDrug Details: Seclidemstat (SP-2577) is under development for the treatment of relapsed...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Seclidemstat Mesylate in Pancreatic Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Seclidemstat Mesylate in Pancreatic CancerDrug Details: Seclidemstat (SP-2577) is under development for the treatment of relapsed...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Seclidemstat Mesylate in Ewing Sarcoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Seclidemstat Mesylate in Ewing SarcomaDrug Details: Seclidemstat (SP-2577) is under development for the treatment of relapsed...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Seclidemstat in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDataÂ’s proprietary machine learning algorithms developed using over 10 years of historical data. Seclidemstat in Solid Tumor Drug Details: Seclidemstat (SP-2577) is under development for the...
-
Product Insights
![]()
Net Present Value Model: Seclidemstat
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Seclidemstat Drug Details Seclidemstat (SP-2577) is...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – seclidemstat
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry seclidemstat Drug Details Seclidemstat (SP-2577) is under development for the treatment of prostate cancer,...
-
Product Insights
EEC Uta Solar PV Park
EEC Uta solar PV Park is a 45.07MW solar PV power project located in Sardinia, Italy. The project is currently in the permitting stage. The project is owned by EEC Solar Srl. EEC Uta solar PV Park profile includes core details such as plant name, technology, capacity, status, plant proponents (owners, developers etc.), owner stakes etc as well as key operational data including generation, year online, decommissioning year, capital expenditure etc. Details on project specific contacts along with relevant news,...
-
Product Insights
EEC Uta Cagliari Solar PV Park
EEC Uta Cagliari solar PV Park is a 22.693MW solar PV power project located in Sardinia, Italy. It is being developed by EEC Solar 2 Srl. The project is currently in the permitting stage. The project is owned by EEC Solar 2 Srl. EEC Uta Cagliari solar PV Park profile includes core details such as plant name, technology, capacity, status, plant proponents (owners, developers etc.), owner stakes etc as well as key operational data including generation, year online, decommissioning year,...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.